Gamers' secret weapon? supplement trial aims to sharpen minds
NCT ID NCT07386964
First seen Jun 27, 2026 · Last updated Aug 21, 2026 · Updated 4 times
Summary
This study tests whether a dietary supplement called Clarity Active Product can improve thinking skills and reduce fatigue in e-gamers. Six hundred adults aged 21 to 45 who play video games at least 5 hours a week will take either the supplement or a placebo for 8 weeks. Researchers will measure changes in cognitive function using a standard questionnaire.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Clarity Active Product (dietary supplement)
- What this could lead to
- If it works, this could point toward a supplement that helps e-gamers think more clearly and feel less tired.
- What could go wrong
- This is an early-stage study with no phase, so results may not be conclusive. The supplement might not outperform placebo, and effects may not apply to non-gamers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 600 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Participants must meet all the following criteria: * Adults, aged 21 - 45 years at the time of electronic consent, inclusive of all ethnicities, races, and gender identities * Assigned sex at birth will determine sex-specific recruitment and surveys (male vs female) employed, when needed * Identifies as a young professional (working 30+ hrs/week) * May identify as an E-gamer (playing video games 5+hrs/week for the past year) * Resides in the United States * Has the opportunity for at least 30% improvement in their primary health outcome * Expresses a willingness to take a study product and not know the product identity (active or placebo) until the end of the study Exclusion Individuals who report any of the following during screening may be excluded from participation: * Report being pregnant, trying to become pregnant, or breastfeeding * Unable to provide a valid US shipping address and mobile phone number * Reports current enrollment in another clinical trial * Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day) * Unable to read and understand English at a 7th grade level * Reports a current and/or recent (up to 3 months ago) major illness and/or surgery that poses a known, significant safety risk. * Reports a diagnosis of cardiac dysfunction, liver or kidney disease that presents a known contraindication and/or a significant safety risk with any of the study product ingredients. * NYHA Class III or IV congestive heart failure, atrial fibrillation, uncontrolled arrhythmias, cirrhosis, end-stage liver disease, stage 3b or 4 chronic kidney disease, or kidney failure * Reports taking medications that have a well-established moderate or severe interaction, posing a substantial safety risk with any of the study product ingredients.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cognitive function are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Radicle Science Inc.
Del Mar, California, 92014, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hands-On nerve stimulation tested as a Drug-Free boost for stroke recovery
- Park golf may sharpen aging brains: a trial puts it to the test
- Can two hours in the heat stress a healthy heart and mind?
- Can a Two-Hour chill reshape heart and brain function?
- Dance might sharpen young minds and bodies — a trial puts it to the test
- Could a smarter pacemaker setting sharpen the mind?